SCHEMBL6072191

SCHEMBL6072191

CCOc1cc2c(c3c1OC(C)(C)C3)C(c1ccc(C(=O)O)c(NCc3ccccc3)c1)=NC(C)(C)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.38
POLB P06746 1/20 0.37
CDC7 O00311 1/20 0.35
ROCK2 O75116 1/20 0.35
MAP4K4 O95819 1/20 0.35
GSK3B P49841 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ASPH Q12797 1/20 0.34
RIOX2 Q8IUF8 1/20 0.34
KDM8 Q8N371 1/20 0.34
KDM4C Q9H3R0 2/20 0.33
KDM5B Q9UGL1 1/20 0.33
KDM6B O15054 1/20 0.33
KDM4A O75164 1/20 0.33
KDM4D Q6B0I6 1/20 0.33
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6072844 0.97 ACLY (0.41) ACLYPOLBCDC7ROCK2MAP4K4
SCHEMBL6072162 0.95 MKNK2 (0.42) POLBCDC7ROCK2MAP4K4GSK3B
SCHEMBL6071890 0.94 POLB (0.36) ACLYPOLBCDC7ROCK2MAP4K4
SCHEMBL6071853 0.94 NPSR1 (0.38) POLBCDC7ROCK2MAP4K4GSK3B
SCHEMBL6072164 0.93 ACLY (0.38) ACLYPOLBKDM4EALDH1A1LMNA
SCHEMBL6072661 0.93 ACLY (0.40) ACLYRAB9ANPC1KDM4EALDH1A1
SCHEMBL6072061 0.93 KDM4E (0.40) ACLYPOLBKDM4EASPHRIOX2
SCHEMBL6072299 0.92 PKM (0.36) ACLYPOLBKDM4EALDH1A1LMNA
SCHEMBL6072284 0.91 IDO1 (0.33) ACLYMKNK2KDM4EALDH1A1LMNA
SCHEMBL6072007 0.91 POLB (0.36) POLBCDC7ROCK2MAP4K4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106048-A1 Furoisoquinoline derivative and use thereof PASCALI, PETROS P. (CY) 2006-05-18 US claimed
EP-1541576-A1 FUROISOQUINOLINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP claimed
US-20060106048-A1 Furoisoquinoline derivative and use thereof PASCALI, PETROS P. (CY) 2006-05-18 US disclosed
EP-1541576-A1 FUROISOQUINOLINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106048-A1 Furoisoquinoline derivative and use thereof PDE3B, PDE2A, PDE3A ACLY 1588/4885POLB 1887/4885CDC7 2101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.